Preface.
Faculty Disclosure.
1 INTRODUCTION AND OVERVIEW.
Additional Reading.
2 BASICS OF PSYCHOPHARMACOLOGY.
2.1 Introduction.
2.3 Pathophysiology: Study of What Goes Wrong.
2.4 Pharmacology.
2.5 Putting It All Together.
Additional Reading.
3 MOOD DISORDERS.
3.1 Introduction.
3.2 Major Depressive Disorder.
3.3 Dysthymic Disorder.
3.4 Bipolar Disorders.
Additional Reading.
4 SCHIZOPHRENIA.
4.1 Brief Description and Diagnostic Criteria.
4.2 Prevalence and Risk Factors.
4.3 Presentation and Clinical Course.
4.4 Initial Evaluation and Differential Diagnosis.
4.5 History of Treatment.
4.6 Current Approach to Treatment.
4.7 Treatment Resistant Schizophrenia.
Additional Reading.
5 ANXIETY DISORDERS.
5.1 Introduction.
5.2 Panic Disorder.
5.3 Generalized Anxiety Disorder.
5.4 Obsessive–Compulsive Disorder.
5.5 Social Anxiety Disorder (Social Phobia).
5.6 Post-Traumatic Stress Disorder.
Additional Reading.
6 SUBSTANCE USE DISORDERS.
6.1 Introduction.
6.2 Brief Description and Diagnostic Criteria.
6.3 Prevalence and Risk Factors.
6.4 Presentation and Clinical Course.
6.5 Initial Evaluation and Differential Diagnosis.
6.6 History of Treatment.
6.7 Current Approaches to Treatment.
6.8 Alcohol Use Disorders.
6.9 Cocaine Use Disorders.
6.10 Nicotine Dependence.
6.11 Opiate Use Disorders.
Additional Reading.
7 EATING DISORDERS.
7.1 Introduction.
7.2 Anorexia Nervosa.
7.3 Bulimia Nervosa.
7.4 Binge-Eating Disorder.
Additional Reading.
8 ATTENTION DEFICIT–HYPERACTIVITY DISORDER.
8.1 Brief Description and Diagnostic Criteria.
8.2 Prevalence and Risk Factors.
8.3 Presentation and Clinical Course.
8.4 Initial Evaluation and Differential Diagnosis.
8.5 History of Pharmacological Treatment.
8.6 Current Approach to Treatment.
Additional Reading.
9 SLEEP DISORDERS.
9.1 Introduction.
9.2 Insomnia.
9.3 Narcolepsy.
Additional Reading.
10 ALZHEIMER’S DISEASE AND OTHER DEMENTIAS.
10.1 Brief Description and Diagnostic Criteria.
10.2 Prevalence and Risk Factors.
10.3 Presentation and Clinical Course.
10.4 Initial Evaluation and Differential Diagnosis.
10.5 History of Pharmacological Treatment.
10.6 Current Approach to Treatment.
Additional Reading.
11 PERSONALITY DISORDERS.
11.1 Introduction.
11.2 Cluster A: Odd and Eccentric Personality Disorders.
11.3 Cluster B: Dramatic and Emotional Personality Disorders.
11.4 Cluster C: Anxious and Fearful Personality Disorders.
Additional Reading.
12 TRAUMATIC BRAIN INJURY.
12.1 Introduction.
12.2 Approaches to Treatment.
Additional Reading.
13 MANAGING SIDE EFFECTS.
13.1 Introduction.
13.2 Norepinephrine-Related Side Effects.
13.3 Dopamine-Related Side Effects.
13.4 Serotonin-Related Side Effects.
13.5 GABA-Related Side Effects.
13.6 Acetylcholine-Related Side Effects.
13.7 Histamine-Related Side Effects.
Index.
Jeffrey E. Kelsey is the author of Principles of Psychopharmacology for Mental Health Professionals, published by Wiley.
Charles Barnet Nemeroff is an American psychiatrist known for his work in treating depression. He is the author of numerous textbooks, papers, and clinical studies.
D. Jeffrey Newport is the author of Principles of Psychopharmacology for Mental Health Professionals, published by Wiley.
"…a comprehensive, readily comprehensible resource for non-prescribing, non-physician mental health professionals…" (E-STREAMS, June 2007) "The authors clearly answer the 'what, why, how and when' of psychopharmacology for the nonprescribing clinician." (Doody's Health Services) "...an excellent first edition that pulls together helpful information for nonphysician mental health professionals who wish to learn more about psychiatric illnesses and pharmacologic treatment." (PsycCRITIQUES, December 6, 2006)
 |
Ask a Question About this Product More... |
|
